Evidence map›Paper›PMID 38875880›Full record

Trial reportDrug and alcohol dependence2024

Offering nurse care management for opioid use disorder in primary care: Impact on emergency and hospital utilization in a cluster-randomized implementation trial.

Jennifer F Bobb, Abisola E Idu, Hongxiang Qiu, Onchee Yu, Denise M Boudreau, Paige D Wartko, Abigail G Matthews, Jennifer McCormack, Amy K Lee, Cynthia I Campbell and 19 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol dependence, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03407638 (PRimary Care Opioid Use Disorders Treatment), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03407638 nacompletednot on this map

PRimary Care Opioid Use Disorders Treatment (PROUD) Trial

TypeinterventionalSponsorKaiser PermanenteRan2018 to 2020Enrolled377,373ConditionsOpioid-use DisorderArmsPROUD Intervention
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Jennifer F BobbKaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Suite 1600, Seattle, WA 98101, USA. Electronic address: jennifer.f.bobb@kp.org.
Abisola E IduKaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Suite 1600, Seattle, WA 98101, USA.
Hongxiang QiuKaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Suite 1600, Seattle, WA 98101, USA.
Onchee YuKaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Suite 1600, Seattle, WA 98101, USA.
Denise M BoudreauKaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Suite 1600, Seattle, WA 98101, USA.
Paige D WartkoKaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Suite 1600, Seattle, WA 98101, USA.
Abigail G MatthewsThe Emmes Company, 401 N Washington St, Suite 700, Rockville, MD 20850, USA.
Jennifer McCormackThe Emmes Company, 401 N Washington St, Suite 700, Rockville, MD 20850, USA.
Amy K LeeKaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Suite 1600, Seattle, WA 98101, USA.
Cynthia I CampbellKaiser Permanente Northern California Division of Research, 2000 Broadway, Oakland, CA 94612, USA.
Andrew J SaxonCenter of Excellence in Substance Addiction Treatment and Education (CESATE), VA Puget Sound Health Care System, 1660 S. Columbian Way, Seattle, WA 98108, USA.
David S LiuNational Institute on Drug Abuse Center for Clinical Trials Network, Three White Flint North, 11601 Landsdown Street, North Bethesda, MD 20852, USA.
Andrea AltschulerKaiser Permanente Northern California Division of Research, 2000 Broadway, Oakland, CA 94612, USA.
Jeffrey H SametBoston University Schools of Medicine and Public Health, Boston Medical Center, Crosstown Center, 801 Massachusetts Ave, Boston, MA 02119, USA.
Thomas F NorthrupUTHealth Houston McGovern Medical School, Department of Family and Community Medicine, 6431 Fannin St, Houston, TX 77030, USA.
Jordan M BraciszewskiHenry Ford Health, Center for Health Policy and Health Services Research, One Ford Place, Suite 5E, Detroit, MI 48202, USA.
Mark T MurphyMultiCare Health System, 315 Martin Luther King Jr. Way, Tacoma, WA 98415, USA.
Julia H ArnstenMontefiore Medical Center, 111 East 210 Street, Bronx, NY 10467, USA; Albert Einstein College of Medicine, 1300 Morris Park Ave, The Bronx, NY 10461, USA.
Chinazo O CunninghamAlbert Einstein College of Medicine, 1300 Morris Park Ave, The Bronx, NY 10461, USA.
Viviana E HorigianDepartment of Public Health Sciences, University of Miami Miller School of Medicine, 1120 NW 14th Street, 10th Floor, Miami, FL 33136, USA.
José SzapocznikDepartment of Public Health Sciences, University of Miami Miller School of Medicine, 1120 NW 14th Street, 10th Floor, Miami, FL 33136, USA.
Joseph E GlassKaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Suite 1600, Seattle, WA 98101, USA.
Ryan M CaldeiroMental Health and Wellness Department, Kaiser Permanente Washington, 1200 SW 27th St, Renton, WA 98057, USA.
Judith I TsuiDivision of General Internal Medicine, Department of Medicine, University of Washington School of Medicine, 1959 NE Pacific St, Seattle, WA 98195, USA.
Rachael P BurganowskiKaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Suite 1600, Seattle, WA 98101, USA.
Zoe M WeinsteinBoston University Schools of Medicine and Public Health, Boston Medical Center, Crosstown Center, 801 Massachusetts Ave, Boston, MA 02119, USA.
Sean M MurphyDepartment of Population Health Sciences, Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, USA.
Noorie HyunKaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Suite 1600, Seattle, WA 98101, USA.
Katharine A BradleyKaiser Permanente Washington Health Research Institute, 1730 Minor Ave., Suite 1600, Seattle, WA 98101, USA.

Funding

Project-003UG1DA013035 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Aimee N Campbell, Jennifer McNeely · 2015 to 2026
$130.3M
The National Drug Abuse Treatment Clinical Trials NetworkUG1DA015831 · NIDA · YALE UNIVERSITY · PI Gail D'Onofrio, Roger D. Weiss · 2015 to 2026
$110.8M
Project-004UG1DA020024 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI Steven J Shoptaw, MADHUKAR H. TRIVEDI · 2015 to 2026
$71.6M
FLORIDA NODE OF THE DRUG ABUSE CLINICAL TRIALS NETWORKU10DA013720 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI METSCH, LISA R, SZAPOCZNIK, JOSE · 2000 to 2015
$56.9M
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials NetworkUG1DA013720 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Daniel J Feaster, Viviana Elizabeth Horigian · 2015 to 2026
$50.6M
Project-002UG1DA040314 · NIDA · KAISER FOUNDATION RESEARCH INSTITUTE · PI Ingrid A Binswanger, CYNTHIA I CAMPBELL · 2015 to 2026
$34.9M
Concept ProjectU10DA020024 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI TRIVEDI, MADHUKAR H. · 2005 to 2015
$22.6M
Institute for Integration of Medicine & Science: A Partnership to Improve HealthUM1TR004538 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ROBERT A CLARK, Kenneth M Hargreaves · 2023 to 2026
$22.3M
Clinical Trials Network: Pacific Northwest Node (CTN-0082, -0131, -0139 and dissemination library)UG1DA013714 · NIDA · UNIVERSITY OF WASHINGTON · PI Mary Akiko Hatch, John M. Roll · 2015 to 2026
$19.8M
Training Program on HIV and Substance Use in the Criminal Justice SystemT32DA037801 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Nabila El-Bassel, Lisa R Metsch · 2014 to 2026
$5.7M
CLC NIH HHS 75N90019D00013NCATS NIH HHS UM1 TR004538NIDA NIH HHS 75N95021D00013NIDA NIH HHS HHSN271201400028CNIDA NIH HHS T32 DA037801NIDA NIH HHS U10 DA013720NIDA NIH HHS U10 DA020024NIDA NIH HHS UG1 DA013035NIDA NIH HHS UG1 DA013714NIDA NIH HHS UG1 DA013720NIDA NIH HHS UG1 DA015831NIDA NIH HHS UG1 DA020024NIDA NIH HHS UG1 DA040314ORFDO NIH HHS 75N99019D00013
6 · The paper itself

Abstract

backgroundPatients with opioid use disorder (OUD) have increased emergency and hospital utilization. The PROUD trial showed that implementation of office-based addiction treatment (OBAT) increased OUD medication treatment compared to usual care, but did not decrease acute care utilization in patients with OUD documented pre-randomization (clinicaltrials.gov/study/NCT03407638). This paper reports secondary emergency and hospital utilization outcomes in patients with documented OUD in the PROUD trial.

methodsThis cluster-randomized implementation trial was conducted in 12 clinics from 6 diverse health systems (March 2015-February 2020). Patients who visited trial clinics and had an OUD diagnosis within 3 years pre-randomization were included in primary analyses; secondary analyses added patients with OUD who were new to the clinic or with newly-documented OUD post-randomization. Outcomes included days of emergency care and hospital utilization over 2 years post-randomization. Explanatory outcomes included measures of OUD treatment. Patient-level analyses used mixed-effect regression with clinic-specific random intercepts.

resultsAmong 1988 patients with documented OUD seen pre-randomization (mean age 49, 53 % female), days of emergency care or hospitalization did not differ between intervention and usual care; OUD treatment also did not differ. In secondary analyses among 1347 patients with OUD post-randomization, there remained no difference in emergency or hospital utilization despite intervention patients receiving 32.2 (95 % CI 4.7, 59.7) more days of OUD treatment relative to usual care.

conclusionsImplementation of OBAT did not reduce emergency or hospital utilization among patients with OUD, even in the sample with OUD first documented post-randomization in whom the intervention increased treatment.

Indexed as

Emergency Service, HospitalOpioid-Related DisordersPrimary Health CareAdultFemaleHospitalizationHumansMaleMiddle AgedOpiate Substitution TreatmentPatient Acceptance of Health CareCluster-randomized trialImplementation trialMassachusetts ModelOffice-based addiction treatmentOpioid use disorderPrimary care

Identifiers

PMID38875880
PMCPMC11281026

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.